INSULIN LISPRO VS VELSULIN BR IN PATIENTS WITH TYPE 1 DIABETES USING INSULIN

胰岛素 Lispro 与 VELSULIN BR 在使用胰岛素的 1 型糖尿病患者中的比较

• 批准号: 6247139
• 负责人: WILLIAM V TAMBORLANE
• 金额: $ 2.68万
• 依托单位: YALE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-04-01 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6247139
• 关键词: biological products; clinical research; clinical trials; combination chemotherapy; diabetes mellitus therapy; drug screening /evaluation; hormone analog; hormone therapy; human subject; human therapy evaluation; hypoglycemic agents; injection /infusion; insulin dependent diabetes mellitus; outcomes research; proinsulin

The more rapid onset and shorter duration of insulin lispro vs human regular insulin suggests that insulin lispro maybe an ideal insulin to use with continous subcutaneous insulin infusion therapy. This study is examining this queston.

与人类相比，赖脯胰岛素起效更快、持续时间更短 常规胰岛素表明赖脯胰岛素可能是一种理想的胰岛素 采用持续皮下胰岛素输注治疗。 这项研究是 检查这个问题。